DETECT Fentanyl and Xylazine Act of 2024
Latest Action
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The DETECT Fentanyl and Xylazine Act of 2024 is a Senate bill introduced in the 118th Congress aimed at addressing issues related to fentanyl and xylazine. The bill was read twice and referred to the Committee on Homeland Security and Governmental Affairs but did not advance further and is currently classified as failed or expired. There is no official summary or full text available for detailed analysis. The bill falls under the policy area of Science, Technology, and Communications, suggesting a focus on technological or scientific measures related to these substances.
This Senate bill intended to address fentanyl and xylazine-related issues did not progress beyond committee referral and lacks publicly available detailed content for full evaluation.
- The bill was introduced in the Senate during the 118th Congress and referred to the Committee on Homeland Security and Governmental Affairs.
- No official summary or full text is available, limiting detailed analysis of its provisions.
- The bill is categorized under Science, Technology, and Communications, indicating a possible focus on detection or technological solutions.
['Federal agencies involved in homeland security and drug enforcement', 'Public health and safety organizations concerned with fentanyl and xylazine', 'Communities affected by fentanyl and xylazine-related issues']
['Lack of publicly available full text limits understanding of implementation requirements and costs.', 'Unclear enforcement mechanisms and authority due to missing detailed provisions.', 'Potential oversight challenges given the absence of detailed legislative language.']
The bill was introduced in the Senate and referred to a relevant committee but did not advance further, resulting in a failed or expired status. The referral to the Committee on Homeland Security and Governmental Affairs aligns with the bill's focus on substances posing public safety risks. The absence of further legislative action suggests limited congressional momentum or prioritization during the session.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased focus on technological detection methods for fentanyl and xylazine if provisions were enacted.', 'Possible influence on future legislation addressing synthetic opioids and related substances.', "Enhanced coordination among federal agencies in drug detection and enforcement could result from the bill's intended measures."]
Due to the absence of an official summary and full bill text, transparency is limited, making it difficult to evaluate the bill's scope, funding, enforcement, and oversight provisions. The bill's failure to progress beyond committee referral further restricts public and congressional scrutiny. Future proposals on similar topics would benefit from comprehensive public documentation to facilitate informed analysis and oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.